Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
Clinical trial NCT06588296 · COMPLETED
Trial details
- NCT number
- NCT06588296
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2025-11-18
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.